
10X Genomics (TXG) Stock Forecast & Price Target
10X Genomics (TXG) Analyst Ratings
Bulls say
10x Genomics is a leading life science technology company, offering innovative solutions that analyze biological systems at a high resolution and scale. With a wide range of product offerings, including the Chromium platform and recent acquisitions such as Prime Mining, the company is in a strong position for growth in the coming years. In line with their history of strong financial performance and strategic investments, we project a positive outlook for 10x Genomics' stock.
Bears say
10x Genomics is facing risks to achieving their price target and recommendation, including competition from other companies in the market and the potential for their technology to become obsolete. Additionally, the company's success is heavily dependent on key customers and any disruptions in their supply chain could have a negative impact on their financial and operational results. These risks should be closely monitored and considered before making any investment decisions.
This aggregate rating is based on analysts' research of 10X Genomics and is not a guaranteed prediction by Public.com or investment advice.
10X Genomics (TXG) Analyst Forecast & Price Prediction
Start investing in 10X Genomics (TXG)
Order type
Buy in
Order amount
Est. shares
0 shares